US Stock MarketDetailed Quotes
TRXDW ASENSUS SURGICAL INC C/WTS 10/03/2025 (TO PUR COM)SER D
- 0.150
- 0.0000.00%
15min DelayClose Sep 18 16:00 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.150Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares0.18052wk High0.00P/B0Float Cap0.00152wk Low--Dividend TTM0Shs Float0.180Historical High--Div YieldTTM0.00%Amplitude0.001Historical Low--Avg Price1Lot Size
ASENSUS SURGICAL INC C/WTS 10/03/2025 (TO PUR COM)SER D Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 104.16%2.21M | 15.06%1.12M | 21.02%8.58M | 120.41%5.43M | -57.51%1.09M | 8.75%1.08M | -8.44%976K | -13.91%7.09M | -0.48%2.46M | -0.31%2.56M |
| Operating revenue | 104.16%2.21M | 15.06%1.12M | 21.02%8.58M | 120.41%5.43M | -57.51%1.09M | 8.75%1.08M | -8.44%976K | -13.91%7.09M | -0.48%2.46M | -0.31%2.56M |
| Cost of revenue | -13.50%2.66M | 3.70%3.06M | 21.00%13.16M | 85.60%4.27M | -34.85%2.87M | 30.98%3.07M | 61.66%2.95M | -2.02%10.87M | 0.48%2.3M | 31.46%4.4M |
| Gross profit | 77.32%-452K | 1.93%-1.93M | -20.95%-4.58M | 602.41%1.17M | 3.31%-1.78M | -47.30%-1.99M | -160.37%-1.97M | -32.16%-3.79M | -12.17%166K | -136.33%-1.84M |
| Operating expense | -6.84%17.39M | -19.98%16.22M | 2.76%73.55M | -4.30%16.5M | 2.87%18.11M | 1.56%18.67M | 10.47%20.27M | 13.04%71.58M | -6.56%17.24M | 7.48%17.61M |
| Selling and administrative expenses | 0.79%9.65M | -20.01%8.02M | 3.29%36.08M | -9.76%7.77M | 2.85%8.71M | 11.39%9.57M | 8.31%10.02M | 6.75%34.93M | -5.91%8.61M | -7.03%8.47M |
| -Selling and marketing expense | -17.85%3.66M | -20.01%3.64M | 14.67%16.92M | -1.02%3.78M | 14.47%4.14M | 23.51%4.45M | 22.43%4.55M | 10.16%14.76M | 18.30%3.82M | 1.80%3.62M |
| -General and administrative expense | 16.98%5.99M | -20.01%4.37M | -5.04%19.16M | -16.73%3.99M | -5.81%4.57M | 2.64%5.12M | -1.17%5.47M | 4.39%20.17M | -19.10%4.79M | -12.67%4.85M |
| Research and development costs | -15.02%7.63M | -20.20%8.09M | 27.92%37.02M | 1.10%8.61M | 37.81%9.29M | 23.81%8.98M | 57.73%10.14M | 49.59%28.94M | 29.58%8.52M | 50.84%6.74M |
| Depreciation amortization depletion | -3.51%110K | 1.79%114K | -94.12%453K | 5.61%113K | -95.25%114K | -95.50%114K | -95.81%112K | -31.51%7.71M | -96.07%107K | -14.48%2.4M |
| -Depreciation and amortization | -3.51%110K | 1.79%114K | -94.12%453K | 5.61%113K | -95.25%114K | -95.50%114K | -95.81%112K | -31.51%7.71M | -96.07%107K | -14.48%2.4M |
| Operating profit | 13.64%-17.84M | 18.38%-18.15M | -3.67%-78.13M | 10.20%-15.33M | -2.29%-19.89M | -4.70%-20.66M | -16.41%-22.24M | -13.87%-75.36M | 6.50%-17.08M | -13.33%-19.45M |
| Net non-operating interest income expense | -159.16%-255K | -71.30%126K | 112.45%1.55M | -24.11%277K | 111.46%406K | 262.18%431K | 698.18%439K | 232.27%731K | 729.55%365K | 236.84%192K |
| Non-operating interest income | -84.69%66K | -71.30%126K | 36.11%1.55M | -17.31%277K | 39.52%406K | 65.77%431K | 72.16%439K | 93.39%1.14M | -0.59%335K | 138.52%291K |
| Non-operating interest expense | --321K | ---- | --0 | --0 | --0 | --0 | ---- | 10.81%410K | -110.24%-30K | 52.31%99K |
| Other net income (expense) | -1,602.70%-7.58M | -1,269.35%-4.42M | -152.37%-1.54M | -84.16%-2M | 216.80%1.23M | -656.25%-445K | -4,137.50%-323K | -116.39%-611K | -142.32%-1.09M | -63.70%387K |
| Gain on sale of security | ---1.83M | --2.12M | --1.23M | ---1.05M | --2.28M | ---- | ---- | ---- | ---- | ---- |
| Special income (charges) | -2,707.88%-5.7M | -6,071.43%-6.48M | -323.42%-1.34M | 36.88%-664K | -187.98%-366K | -222.29%-203K | -168.18%-105K | -107.16%-316K | -140.81%-1.05M | 249.64%416K |
| -Less：Restructuring and merger&acquisition | 2,707.88%5.7M | 6,071.43%6.48M | 186.46%964K | 447.17%290K | 187.98%366K | 133.95%203K | 168.18%105K | 28.75%-1.12M | 102.06%53K | -249.64%-416K |
| -Less:Impairment of capital assets | ---- | ---- | -73.86%374K | -62.56%374K | --0 | ---- | ---- | --1.43M | --999K | --0 |
| Other non- operating income (expenses) | 78.51%-52K | 72.94%-59K | -386.78%-1.44M | -752.94%-290K | -2,265.52%-686K | -181.40%-242K | -49.32%-218K | -122.76%-295K | -183.33%-34K | -102.16%-29K |
| Income before tax | -24.18%-25.67M | -1.46%-22.45M | -3.82%-78.12M | 4.15%-17.06M | 3.22%-18.26M | -5.84%-20.67M | -16.19%-22.13M | -20.90%-75.24M | -13.70%-17.8M | -17.66%-18.87M |
| Income tax | 725.00%75K | -49.45%46K | -1.26%314K | 89.36%178K | 3.64%57K | -114.12%-12K | 8.33%91K | 41.33%318K | -58.95%94K | 71.88%55K |
| Net income | -24.62%-25.75M | -1.26%-22.5M | -3.80%-78.43M | 3.66%-17.24M | 3.20%-18.32M | -5.32%-20.66M | -16.15%-22.22M | -20.97%-75.56M | -12.65%-17.89M | -17.77%-18.92M |
| Net income continuous Operations | -24.62%-25.75M | -1.26%-22.5M | -3.80%-78.43M | 3.66%-17.24M | 3.20%-18.32M | -5.32%-20.66M | -16.15%-22.22M | -20.97%-75.56M | -12.65%-17.89M | -17.77%-18.92M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -24.62%-25.75M | -1.26%-22.5M | -3.80%-78.43M | 3.66%-17.24M | 3.20%-18.32M | -5.32%-20.66M | -16.15%-22.22M | -20.97%-75.56M | -12.65%-17.89M | -17.77%-18.92M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -24.62%-25.75M | -1.26%-22.5M | -3.80%-78.43M | 3.66%-17.24M | 3.20%-18.32M | -5.32%-20.66M | -16.15%-22.22M | -20.97%-75.56M | -12.65%-17.89M | -17.77%-18.92M |
| Basic earnings per share | ||||||||||
| Diluted earnings per share | ||||||||||
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data